Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System

NCT: NCT07503236 · RECRUITING

NCT IDNCT07503236
StatusRECRUITING
Start Date2026-07-02
SponsorNyra Medical, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Safety and performance evaluation of the CARLEN System in patients with functional mitral valve regurgitation.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑